Anti-cancer activity of 9-nitrocamptothecin liposome aerosol in mice.
Knight
V
V
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA.
Koshkina
N
N
Waldrep
C
C
Giovanella
B C
BC
Kleinerman
E
E
Gilbert
B
B
D000336:Aerosols; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D008081:Liposomes; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000556:secondary; D051379:Mice; D008819:Mice, Nude; D008854:Microscopy, Electron; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D012516:Osteosarcoma / Q000188:drug therapy / Q000473:pathology / Q000556:secondary; D010316:Particle Size; D014183:Transplantation, Heterologous
D000336:Aerosols; D000970:Antineoplastic Agents; D008081:Liposomes; C079905:rubitecan; D002166:Camptothecin